ArticleAntimicrobial agents and chemotherapy2026
Establishment of epidemiological cutoff values for clinically relevant
Abstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Methodological considerations for the establishment of epidemiological cutoff values forAntimicrobial agents and chemotherapy · 2026Article
- Towards standardized antifungal susceptibility testing for Sporothrix brasiliensis.The Journal of antimicrobial chemotherapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Amanda R Dos SantosDepartamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-5577-4498
Alexandro BonifazDermatology Service, Mycology Department, Hospital General de México, "Dr. Eduardo Liceaga", Mexico City, Mexico.
Amanda BombassaroDepartment of Public Health, Federal University of Paraná, Curitiba, Brazil.
Ana Caroline de Sá MachadoLaboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos (Lapclin-Dermzoo), Fundação Oswaldo Cruz (Fiocruz), Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil.
Anderson M RodriguesDepartment of Microbiology, Immunology, and Parasitology, Discipline of Cellular Biology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Andrew M BormanUK Health Security Agency National Mycology Reference Laboratory, Bristol and MRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.ORCID 0000-0003-0585-5721
Arunaloke ChakrabartiDoodhadhari Burfani Hospital and Research Institute, Haridwar, India.
Anuradha ChowdaryMedical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, India.ORCID 0000-0002-2028-7462
Bruno RediguieriMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Elizabeth M JohnsonUK Health Security Agency National Mycology Reference Laboratory, Bristol and MRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.
Ferry HagenRadboudumc-CWZ Center of Expertise for Mycology, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, the Netherlands.ORCID 0000-0002-5622-1916
Flavio Queiroz-TellesDepartment of Public Health, Federal University of Paraná, Curitiba, Brazil.
Gloria M GonzalezFaculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
Guillermo Garcia-EffronConsejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Universidad Nacional del Litoral, Santa Fe de la Vera Cruz, Santa Fe, Argentina.
Isabella Dib Ferreira GremiãoLaboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos (Lapclin-Dermzoo), Fundação Oswaldo Cruz (Fiocruz), Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil.
Jacques F MeisRadboudumc-CWZ Center of Expertise for Mycology, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, the Netherlands.
Juliana Possato Fernandes TakahashiCentro de Patologia, Núcleo de Patologia Quantitativa, Instituto Adolfo Lutz, São Paulo, Brazil.
Luana Pereira Borba Dos SantosLaboratório de Biologia Celular de Fungos, Centro de Pesquisas em Medicina de Precisão, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Marcia S C MelhemFaculdade de Medicina, Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Paola CappellanoMicrobiology Section, Grupo Fleury, São Paulo, São Paulo, Brazil.
Raimunda Sâmia Nogueira BrilhanteDepartment of Pathology and Legal Medicine, School of Medicine, One Health Microbiology Laboratory, Postgraduate Program in Medical Microbiology, Postgraduate Program in Medical Sciences, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Sandro Antonio PereiraLaboratório de Pesquisa Clínica em Dermatozoonoses em Animais Domésticos (Lapclin-Dermzoo), Fundação Oswaldo Cruz (Fiocruz), Instituto Nacional de Infectologia Evandro Chagas (INI), Rio de Janeiro, Brazil.
Sarah Santos GonçalvezDepartment of Pathology, Universidade Federal do Espírito Santo (UFES), Vitória-ES, Brazil.
Sarah KiddNational Mycology Reference Centre, SA Pathology, Adelaide, Australia.
Sean X ZhangDepartment of Pathology, Johns Hopkins University School of Medicine & Johns Hopkins Hospital, Baltimore, Maryland, USA.ORCID 0000-0003-1166-2563
Shivaprakash RudramurthyDepartment of Medical Microbiology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Sonia RozentalLaboratório de Biologia Celular de Fungos, Centro de Pesquisas em Medicina de Precisão, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Susana CordobaMycology Department of INEIA ANLIS "Dr. C. G. Malbran", Buenos Aires, Argentina.
Theun De GrootRadboudumc-CWZ Center of Expertise for Mycology, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, the Netherlands.
Wei LiuPeking University First Hospital, Beijing, China.ORCID 0000-0002-3576-6108
Nathan P WiederholdDepartment of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.ORCID 0000-0002-2225-5122
Eelco F J MeijerRadboudumc-CWZ Center of Expertise for Mycology, Canisius-Wilhelmina Hospital (CWZ), Nijmegen, the Netherlands.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4383-5994
Philippe J DufresneLaboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec (INSPQ), Sainte-Anne-de-Bellevue, Québec, Canada.ORCID 0000-0001-5871-3933
Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo 2025/12147-3
Abstract
Sporotrichosis is a globally distributed subcutaneous mycosis caused mainly by
Indexed as
Antifungal AgentsSporothrixSporotrichosisAmphotericin BAnimalsCatsHumansItraconazoleMicrobial Sensitivity TestsTerbinafineTriazolesVoriconazoleAmphotericin BAntifungal AgentsItraconazoleposaconazoleTerbinafineTriazolesVoriconazoleantifungal susceptibility testingepidemiological cutoff values (ECV)Sporothrix spp.sporotrichosiszoonotic
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.